Last updated 2024-09-24T18:05:26Z

RealizedCare

RealizedCare's gameChange product uses guided simulations to specifically target agoraphobic symptoms. The VR-based therapy aims to impact suicide prevention by addressing isolation, allowing Veterans with agoraphobia and anxious social avoidance to learn coping skills in a safe environment. RealizedCare aims to use gameChange to support Veterans by reaching those at higher risk of suicidal thoughts and behaviors.

Origin:

April 2022, Elizabethtown, KY

Awards and Recognition:

Mission Daybreak Grand challenge winner, FDA Breakthrough Device Designation as the World’s 1st Immersive Therapeutic for Serious Mental Illness

Partners:

Office of Healthcare Innovation and Learning (OHIL), Office of Suicide Prevention (OSP), VA Immersive

Overview

Problem

Agoraphobia, anxious social avoidance, and isolation are linked to mental illness. By addressing these root causes in the Veteran population, specifically among Veterans at high risk for suicidal ideation, RealizedCare aims to address the problem of Veteran suicide.

Solution

RealizedCare’s gameChange uses guided simulations to target agoraphobia symptoms in a safe VR-based environment. Through gameChange, Veterans will be able to practice interactions common in public places, allowing them to practice emotional regulation and build self-efficacy. GameChange was used in the world's first large-scale clinical trial of VR technolog ... RealizedCare’s gameChange uses guided simulations to target agoraphobia symptoms in a safe VR-based environment. Through gameChange, Veterans will be able to practice interactions common in public places, allowing them to practice emotional regulation and build self-efficacy. GameChange was used in the world's first large-scale clinical trial of VR technology to treat severe mental illness. See more

Links

Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses Clinical Trial Results published in the Lancet

Evidence generation plan for virtual reality technologies for treating severe agoraphobic avoidance in people with psychosis Publication of NICE Early Value Assessment of gameChange for use with U.K. patients experiencing severe agoraphobic avoidance

Results

RealizedCare’s pilot study with the Wounded Warrior Project’s Independence Program resulted in 80% engagement and significant reductions in agoraphobic avoidance, distress, depression, and anxiety.

Contact

Comment

Comments and replies are disabled for retired innovations and non-VA users.

About

Original team

Risa Weisberg

Chief Clinical Officer

Erin Conwell

Director of Marketing

Search tags

Extended Reality (XR) Mental Health Suicide Prevention

We’re here anytime, day or night – 24/7